<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-18T02:13:58Z</responseDate><request verb="GetRecord" identifier="oai:www.recercat.cat:20.500.12327/3054" metadataPrefix="didl">https://recercat.cat/oai/request</request><GetRecord><record><header><identifier>oai:recercat.cat:20.500.12327/3054</identifier><datestamp>2025-10-22T11:09:15Z</datestamp><setSpec>com_2072_4428</setSpec><setSpec>com_2072_4427</setSpec><setSpec>col_2072_487898</setSpec></header><metadata><d:DIDL xmlns:d="urn:mpeg:mpeg21:2002:02-DIDL-NS" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="urn:mpeg:mpeg21:2002:02-DIDL-NS http://standards.iso.org/ittf/PubliclyAvailableStandards/MPEG-21_schema_files/did/didl.xsd">
   <d:DIDLInfo>
      <dcterms:created xmlns:dcterms="http://purl.org/dc/terms/" xsi:schemaLocation="http://purl.org/dc/terms/ http://dublincore.org/schemas/xmls/qdc/dcterms.xsd">2025-10-22T11:09:15Z</dcterms:created>
   </d:DIDLInfo>
   <d:Item id="hdl_20.500.12327_3054">
      <d:Descriptor>
         <d:Statement mimeType="application/xml; charset=utf-8">
            <dii:Identifier xmlns:dii="urn:mpeg:mpeg21:2002:01-DII-NS" xsi:schemaLocation="urn:mpeg:mpeg21:2002:01-DII-NS http://standards.iso.org/ittf/PubliclyAvailableStandards/MPEG-21_schema_files/dii/dii.xsd">urn:hdl:20.500.12327/3054</dii:Identifier>
         </d:Statement>
      </d:Descriptor>
      <d:Descriptor>
         <d:Statement mimeType="application/xml; charset=utf-8">
            <oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
               <dc:title>Development of a Fully Protective Pandemic Avian Influenza Subunit Vaccine in Insect Pupae</dc:title>
               <dc:creator>Falcón, Ana</dc:creator>
               <dc:creator>Martínez-Pulgarín, Susana</dc:creator>
               <dc:creator>López-Serrano, Sergi</dc:creator>
               <dc:creator>Reytor, Edel</dc:creator>
               <dc:creator>Cid, Miguel</dc:creator>
               <dc:creator>Núñez, Maria del Carmen</dc:creator>
               <dc:creator>Córdoba, Lorena</dc:creator>
               <dc:creator>Darji, Ayub</dc:creator>
               <dc:creator>Escribano, José M.</dc:creator>
               <dc:contributor>Producció Animal</dc:contributor>
               <dc:contributor>Sanitat Animal</dc:contributor>
               <dc:description>In this study, we pioneered an alternative technology for manufacturing subunit influenza&#xd;
hemagglutinin (HA)-based vaccines. This innovative method involves harnessing the pupae of the&#xd;
Lepidoptera Trichoplusia ni (T. ni) as natural biofactories in combination with baculovirus vectors&#xd;
(using CrisBio® technology). We engineered recombinant baculoviruses encoding two versions&#xd;
of the HA protein (trimeric or monomeric) derived from a pandemic avian H7N1 virus A strain&#xd;
(A/chicken/Italy/5093/99). These were then used to infect T. ni pupae, resulting in the production&#xd;
of the desired recombinant antigens. The obtained HA proteins were purified using affinity chromatography, consistently yielding approximately 75 mg/L of insect extract. The vaccine antigen&#xd;
effectively immunized poultry, which were subsequently challenged with a virulent H7N1 avian&#xd;
influenza virus. Following infection, all vaccinated animals survived without displaying any clinical&#xd;
symptoms, while none of the mock-vaccinated control animals survived. The CrisBio®-derived&#xd;
antigens induced high titers of HA-specific antibodies in the vaccinated poultry, demonstrating&#xd;
hemagglutination inhibition activity against avian H7N1 and human H7N9 viruses. These results&#xd;
suggest that the CrisBio® technology platform has the potential to address major industry challenges&#xd;
associated with producing recombinant influenza subunit vaccines, such as enhancing production&#xd;
yields, scalability, and the speed of development, facilitating the global deployment of highly effective&#xd;
influenza vaccines.</dc:description>
               <dc:date>2025-10-22T11:09:15Z</dc:date>
               <dc:date>2025-10-22T11:09:15Z</dc:date>
               <dc:date>2024-05-23</dc:date>
               <dc:type>info:eu-repo/semantics/article</dc:type>
               <dc:identifier>Falcón, Ana, Susana Martínez-Pulgarín, Sergi López-Serrano, Edel Reytor, Miguel Cid, Maria Del Carmen Nuñez, Lorena Córdoba, Ayub Darji, and José M. Escribano. 2024. “Development of a Fully Protective Pandemic Avian Influenza Subunit Vaccine in Insect Pupae.” Viruses 16 (6): 829. https://doi.org/10.3390/v16060829.</dc:identifier>
               <dc:identifier>1999-4915</dc:identifier>
               <dc:identifier>http://hdl.handle.net/20.500.12327/3054</dc:identifier>
               <dc:identifier>https://doi.org/10.3390/v16060829</dc:identifier>
               <dc:language>eng</dc:language>
               <dc:relation>Viruses</dc:relation>
               <dc:rights>http://creativecommons.org/licenses/by/4.0/</dc:rights>
               <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
               <dc:rights>Attribution 4.0 International</dc:rights>
               <dc:publisher>MDPI</dc:publisher>
            </oai_dc:dc>
         </d:Statement>
      </d:Descriptor>
   </d:Item>
</d:DIDL></metadata></record></GetRecord></OAI-PMH>